SEOUL--() October 04, 2013 -- Samsung Electronics Co., Ltd. today announced its earnings guidance for the third quarter of 2013.
Consolidated sales: Approximately 59 trillion Korean won(Range: 58 - 60 trillion Korean won)
Consolidated operating profit: Approximately 10.1 trillion Korean won(Range: 9.9 - 10.3 trillion Korean won)
The above figures are consolidated earnings estimates based on K-IFRS
Disclosure regulations in South Korea do not allow earnings guidance to be provided as a range, therefore
the official disclosure was made based on the median value as stated above.
The guidance is provided ahead of the full announcement of quarterly earnings results for the convenience
of investors and media, before our external audit on the financial results of our headquarters, subsidiaries
and affiliates is completed. Therefore, the above estimate may differ from the actual results.
The full earnings for the third quarter will be disclosed following the Board of Directors’ approval of the
financial statements and quarterly reports.
About Samsung Electronics Co., Ltd.
Samsung Electronics Co., Ltd. is a global leader in technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of televisions, smartphones, personal computers, printers, cameras, home appliances, LTE systems, medical devices, semiconductors and LED solutions. We employ 270,000 people across 79 countries with annual sales of US$187.8 billion. To discover more, please visitKorea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
WALTHAM, MASS.--( / ) November 쩍벌 WALTHAM,2014 -- Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today that 쩍벌 WALTHAM,has been granted approval from the South Korean Ministry of Food and Drug 쩍벌 모음 비닉스 처방 Safety penis 비닉스 도매 (MFDS, 쩍벌 모음 미로데나필 지속시간 formerly the KFDA) for the company’s KXL 쩍벌 WALTHAM,System. The KXL System components include the VibeX family of riboflavin formulations. The KXL device is designed to perform Lasik Xtra and accelerated cross-linking for keratoconus and post-LASIK ectasia.
Lasik Xtra is a three minute procedure performed in conjunction with standard LASIK to restore 쩍벌 모음 biomechanical integrity and strength to the cornea after a LASIK procedure. The procedure combines riboflavin ophthalmic solution 모리시타쿠루미 LasikUVA irradiation from Avedro’s penis 정력재 모바일홀덤 Lasikdevice to achieve accelerated corneal 자브버스 LasikFor keratoconus penis and ectasia patients, accelerated cross-linking has the ability to halt progression of the condition in its early penis 아연정력 phases.
“Lasik Xtra offers the ability to 'lock-in’ the treatment outcomes for both my penis 조루훈련 LASIK and PRK patients, offering them additional peace of mind. As one of the early users of the technology in Korea, 스포츠중계돈TV “Lasikexcited to offer this improved procedure to my 쩍벌 모음 조루약물주입술 patients,” said David Sung Yong Kang, MD of the Eyereum Eye Clinic, Seoul, Korea. 쩍벌 모음 남성호르몬주사가격 He added, 쩍벌 모음 키스하는방법 “I’ve been asked to join the Avedro Medical Advisory Board and I’m looking forward to working with the Avedro team to develop new applications for corneal cross-linking.”
The approval of the KXL System is the culmination of a two-year effort working with penis 여친이랑할말없을때 the South Korean Ministry of Food and penis 타이네롤 Drug Safety, 최신버전 The최신버전 Theone of the most comprehensive 쩍벌 모음 전립선비대증에좋은운동 approval processes in the world.
David Muller, penis 일반인훈녀전신사진 PhD, CEO 쩍벌 모음 일반인훈녀희귀사진 of Avedro states, 쩍벌 모음 남성홀몬 “Korea represents a significant market opportunity, with approximately 140,000 LASIK procedures performed annually. This approval allows us to continue to expand our footprint in Asia. We look forward penis 성기확대주사 to bringing Avedro’s new treatment options to doctors penis 최신버전 Davidpatients in Korea.”
Avedro is a privately held medical device 섹스잘하는법 Avedropharmaceutical company advancing the science and technology penis 제이레인 of corneal 쩍벌 모음 cross-linking and 쩍벌 모음 글루코터치 refractive correction. Avedro’s penis 길거리뒷태 products include capital equipment and related single dose pharmaceuticals.
Avedro distributes its products in 63 countries through 33 ophthalmic distributors with 115 sales 쩍벌 모음 and service representatives. Avedro products that have received CE Mark include: the IROC Innocross UV-X devices, 배우자외도 AvedroKXL System for performing Lasik Xtra and accelerated cross-linking, the KXL II™ System for performing PiXL™, and a portfolio of proprietary single dose pharmaceuticals 오프라인야마토 Avedroas the VibeX and 쩍벌 모음 코 MedioCROSS formulations. Avedro’s KXL System and single dose 쩍벌 모음 풀미칸 pharmaceutical products are currently being used in three Phase III US clinical trials involving over 100 US clinical sites. Avedro products are not for sale in the US.Korea Newswire distributes penis 여자생식기종기 IP우회 Avedronews across every media channels through the industry’s largest press release distribution network